BioCentury
ARTICLE | Financial News

InterMune raises $76 million

August 17, 2000 7:00 AM UTC

ITMN, which markets its Actimmune interferon gamma-1b to treat chronic granulomatous disease and severe malignant osteopetrosis, raised $76 million through the private placement of 2 million shares at...